- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Children hospitalized with COVID 19 or MIS C who have lingering complications - Video
Overview
As part of the national Overcoming COVID-19 study, investigators led by Adrienne Randolph, of Boston Children's surveyed family caregivers of patients under age 21 who were hospitalized with COVID-19 or multisystem inflammatory syndrome in children (MIS-C)
Of these children and youth, roughly 40 percent were hospitalized with acute COVID-19 and roughly 60 percent with MIS-C. Fifty percent and 86 percent, respectively, were admitted to the intensive care unit.
At two- to four-month follow up, 27 percent of patients with acute COVID-19 and 30 percent of those with MIS-C had persistent symptoms, activity impairment, or both.
Of the children and adolescents with lingering symptoms, the most common symptoms were: fatigue or weakness, shortness of breath, cough, headache, muscle and body aches, fever.
Activity impairment was somewhat more common after MIS-C than after acute COVID-19. Three factors predicted an increased risk for a prolonged recovery or activity impairment:
more organ system involvement in patients with acute COVID-19 underlying respiratory conditions (usually asthma) in patients with MIS-C obesity in patients with MIS-C.
"Now that vaccines are available, I strongly recommend that children and adolescents get vaccinated," lead rsearcher Adrienne Randolph says. "We know that patients can be re-infected even if they've had COVID-19, and we previously showed that vaccination can prevent MIS-C and severe COVID-19."
Ref:
Adrienne Randolph et. al, PEDIATRICS, 12-AUG-2022
Speakers
Isra Zaman
B.Sc Life Sciences, M.Sc Biotechnology, B.Ed